Clinical trial
A Phase I and II Study of Stereotactic Body Radiation Therapy (SBRT) for Low and Intermediate Risk Prostate Cancer (SBRT Prostate)
NCT00547339 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I and II Study of Stereotactic Body Radiation Therapy (SBRT) for Low and Intermediate Risk Prostate Cancer (SBRT Prostate)
- Lead sponsor
- University of Texas Southwestern Medical Center
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- July 31, 2006
- Completion date
- November 28, 2022
- Enrollment
- 94 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer